The NK1 receptor antagonist serlopitant for treatment of chronic pruritus-Reference-Cited by-同舟云学术

The NK1 receptor antagonist serlopitant for treatment of chronic pruritus

Published:2019-07-04 Issue:8 Volume:28 Page:659-666
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ständer Sonja¹,Spellman Mary C.²,Kwon Paul²,Yosipovitch Gil³

Affiliation:

1. Dermatology and Neurodermatology, Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany

2. Department of Clinical Development, Menlo Therapeutics Inc, Redwood City, CA, USA

3. Miami Itch Center, Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA

Funder

Menlo Therapeutics

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/13543784.2019.1638910

Reference47 articles.

1. British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018

2. Chronic Pruritus in the Absence of Skin Disease: Pathophysiology, Diagnosis and Treatment

3. Incidence and Determinants of Chronic Pruritus: A Population-based Cohort Study

4. Prevalence of Chronic Pruritus in Germany: Results of a Cross-Sectional Study in a Sample Working Population of 11,730

5. Epidemiology of Itch

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of pruritus in prurigo nodularis;Frontiers in Immunology;2023-11-23

2. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma;Clinical and Experimental Medicine;2023-08-09

3. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs;Expert Opinion on Investigational Drugs;2023-06-03

4. Chronic pruritus: From pathophysiology to drug design;Biochemical Pharmacology;2023-06

5. The Activity of Substance P (SP) on the Corneal Epithelium;Journal of Clinical & Translational Ophthalmology;2023-03-27